The FDA has reversed its decision to reject Moderna's application for a new flu vaccine, following backlash and pressure from the White House amid concerns over declining public support for vaccine changes during midterms. Meanwhile, there have been leadership shake-ups at HHS, including Jim O'Neill stepping down as deputy secretary and acting CDC director due to the unpopularity of recent vaccine schedule alterations. These developments underscore the political nature of health policy decisions under the current administration and potential implications for drug manufacturers and future vaccine development. The changes also highlight the White House's efforts to stabilize public perception ahead of upcoming elections, impacting various aspects of healthcare regulation and oversight.
Read the full article at KFF Health News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
